Keywords: Multiple Sclerosis, Machine Learning/Artificial Intelligence, Quantitative MRI; qMRI; Contrast enhanced imaging; active lesions
Motivation: The gold standard way for assessing Multiple sclerotic (MS) disease activity is by identifying new active lesions using contrast enhanced imaging. The repeated use of gadolinium injections for MS patients constitute a major concern due to long-term accumulation and even breakdown of this agent in the brain and body without efficient clearance.
Goal(s): Classify active vs. inactive MS lesions using quantitative MRI (qMRI) without the need for contrast-enhanced imaging.
Approach: Machine learning classifier trained on qMRI features of MS lesions.
Results: qMRI profiling has the potential to classify MS lesions into active/inactive state with accuracy of 81.7 ± 10 %.
Impact: Multiple sclerosis disease activity is assessed using contrast-enhanced MRI. Recently, concerns have been raised regarding the long-term accumulation and breakdown of contrast agents in the brain. This study introduces a qMRI-based and contrast-free approach for assessing multiple sclerosis disease activity.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords